Wafaa Mamilli will join Roche as the company's new Chief Digital Technology Officer in February. This follows expansive roles ...
Relating price to CFO (cash from operations), it is clear that Novo Nordisk is much cheaper than Eli Lilly. In particular, Novo Nordisk's current value is slightly below the 10-year average ...
Eli Lilly's sales growth is coming short of expectations, which is a problem considering its valuation. The company does have a vast lineup and a deep pipeline that go beyond diabetes and obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback